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Background
Cardiac complications mainly related to myocardial iron
overload (MIO) remain the main cause of morbidity and
mortality in thalassemia major (TM). Thalassemia cardi-
omyopathy is treatable and partly reversible if appropri-
ate chelation therapy is instituted in time. The validated
multislice multiecho T2* Cardiovascular Magnetic Reso-
nance (CMR) technique has permitted to quantify seg-
mental and global myocardial iron burden detecting
different patterns of iron overload. Aim of our study
was to verify the risk of cardiac complications related to
different patterns of MIO in a large cohort of TM
patients.
Methods
We considered 812 TM patients for who CMR and car-
diac data were collected in a central data base. Three
short-axis views (basal, medium, apical) of the left ven-
tricle were acquired using a multislice multiecho T2*
sequence. Using a previously validated software the 16
segmental T2* values and the mean global heart T2*
value were provided. A conservative cut off of 20 ms
was considered the limit of normal for the segmental
and global T2* values.
Results
We identified 4 groups of patients: group I (17%) with
homogeneous MIO (all segments with T2*<20 ms),
group II (12%) with heterogeneous MIO (some seg-
ments with T2*<20 ms and others with T2*≥20 ms) and
global heart T2*<20 ms; group III (29%) with
heterogeneous MIO and global heart T2*≥20 ms; group
IV (42%) with no MIO (all segments with T2*≥20 ms).
The percentage of patients with cardiac complications
was significantly different in the 4 groups (group I
24.6%, group II 20.6%, group III 8.4%; group IV 16.4%;
P<0.0001). In particular, the percentage of patients with
heart failure was significantly different in the 4 groups
(group I 17.4%, group II 16.5%, group III 4.2%, group IV
8.3%; P<0.0001). No significant differences were found
among groups in the percentage of arrhythmias and pul-
monary hypertension. Odds Ratio for cardiac complica-
tions was 1.7 (1.0-2.7 OR 95% CI; P=.041) for patients
with homogeneous MIO vs patients with no MIO. Odds
Ratio for heart failure was 2.3 (1.3-4.2 OR 95% CI;
P=0.004) for patients with homogeneous MIO versus
patients with no MIO and 2.2 (1.1-4.2 OR 95% CI;
P=.020) for patients with heterogeneous MIO and global
heart T2*<20 ms versus patients with no MIO.
Conclusions
Homogeneous MIO predicts a significantly higher risk
to develop cardiac complications, especially heart failure,
suggesting an intensive chelation therapy in this group
of patients.
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Table 1
Homogeneous
MIO (N=138)
Heterogeneous MIO and global
Heart T2* < 20 ms (N=97)
Heterogeneous MIO and global Heart
T2* ≥ 20 ms (N=238)
No MIO
(N=339)
P-
value
Sex (M/F) 67/71 38/59 119/119 157/172 0.304
Age (years) 28.9 ± 7.4 30.8 ± 7.4 30.4 ± 8.9 31.1 ± 8.9 0.069
Hb pre-transfusion
(g/dl)
9.7 ± 0.6 9.6 ± 0.5 9.7 ± 0.6 9.6 ± 0.8 0.309
Ferritin levels (ng/l) 2454 ± 1969 2043 ± 1796 1328 ± 1277 1114 ±
1004
<0.0001
Cardiac disease, n
(%)
34 (24.6%) 20 (20.6%) 20 (8.4%) 56 (16.5%) <0.0001
Heart failure, n (%) 24 (17.4%) 16 (16.5%) 10 (4.2%) 28 (8.3%) <0.0001
Arrhythmias, n (%) 13 (9.4%) 6 (6.2%) 8 (3.4%) 23 (6.8%) 0.112
Pulmonary
hypertension, n (%)
3 (2.2%) 1 (1.0%) 4 (1.7%) 14 (4.1%) 0.192
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